These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 24224794)
1. Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain. Cai G; Napolitano JG; McAlpine JB; Wang Y; Jaki BU; Suh JW; Yang SH; Lee IA; Franzblau SG; Pauli GF; Cho S J Nat Prod; 2013 Nov; 76(11):2009-18. PubMed ID: 24224794 [TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial terpenoids from Juniperus communis L. (Cuppressaceae). Gordien AY; Gray AI; Franzblau SG; Seidel V J Ethnopharmacol; 2009 Dec; 126(3):500-5. PubMed ID: 19755141 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis. Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
6. Hirsutellide A, a new antimycobacterial cyclohexadepsipeptide from the entomopathogenic fungus Hirsutella kobayasii. Vongvanich N; Kittakoop P; Isaka M; Trakulnaleamsai S; Vimuttipong S; Tanticharoen M; Thebtaranonth Y J Nat Prod; 2002 Sep; 65(9):1346-8. PubMed ID: 12350163 [TBL] [Abstract][Full Text] [Related]
7. Two piperazic acid-containing cyclic hexapeptides from Streptomyces alboflavus 313. Wei S; Fan L; Wu W; Ji Z Amino Acids; 2012 Nov; 43(5):2191-8. PubMed ID: 22543750 [TBL] [Abstract][Full Text] [Related]
8. Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity. Daletos G; Kalscheuer R; Koliwer-Brandl H; Hartmann R; de Voogd NJ; Wray V; Lin W; Proksch P J Nat Prod; 2015 Aug; 78(8):1910-25. PubMed ID: 26213786 [TBL] [Abstract][Full Text] [Related]
9. Nocardiamides A and B, two cyclohexapeptides from the marine-derived actinomycete Nocardiopsis sp. CNX037. Wu ZC; Li S; Nam SJ; Liu Z; Zhang C J Nat Prod; 2013 Apr; 76(4):694-701. PubMed ID: 23586970 [TBL] [Abstract][Full Text] [Related]
10. Anti-tuberculosis activities of the crude methanolic extract and purified fractions of the bulb of Crinum jagus. Akintola AO; Kehinde AO; Adebiyi OE; Ademowo OG Niger J Physiol Sci; 2013 Dec; 28(2):135-40. PubMed ID: 24937387 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of Mycobacterium tuberculosis to extracts of Eucalyptus camaldulensis and Eucalyptus torelliana and isolated compounds. Lawal TO; Adeniyi BA; Adegoke AO; Franzblau SG; Mahady GB Pharm Biol; 2012 Jan; 50(1):92-8. PubMed ID: 22129202 [TBL] [Abstract][Full Text] [Related]
12. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis. Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240 [TBL] [Abstract][Full Text] [Related]
13. An antimycobacterial cyclodepsipeptide from the entomopathogenic fungus Ophiocordyceps communis BCC 16475. Haritakun R; Sappan M; Suvannakad R; Tasanathai K; Isaka M J Nat Prod; 2010 Jan; 73(1):75-8. PubMed ID: 20028029 [TBL] [Abstract][Full Text] [Related]
14. Cyclic Hexapeptides from the Deep South China Sea-Derived Streptomyces scopuliridis SCSIO ZJ46 Active Against Pathogenic Gram-Positive Bacteria. Song Y; Li Q; Liu X; Chen Y; Zhang Y; Sun A; Zhang W; Zhang J; Ju J J Nat Prod; 2014 Aug; 77(8):1937-41. PubMed ID: 25072108 [TBL] [Abstract][Full Text] [Related]
16. Lanostane-type triterpenes from the mushroom Astraeus pteridis with antituberculosis activity. Stanikunaite R; Radwan MM; Trappe JM; Fronczek F; Ross SA J Nat Prod; 2008 Dec; 71(12):2077-9. PubMed ID: 19067555 [TBL] [Abstract][Full Text] [Related]
17. Purity-activity relationships of natural products: the case of anti-TB active ursolic acid. Jaki BU; Franzblau SG; Chadwick LR; Lankin DC; Zhang F; Wang Y; Pauli GF J Nat Prod; 2008 Oct; 71(10):1742-8. PubMed ID: 18798682 [TBL] [Abstract][Full Text] [Related]
18. Structural Sequencing of Oligopeptides Aided by Gao W; McAlpine JB; Choules MP; Napolitano JG; Lankin DC; Simmler C; Ho NA; Lee H; Suh JW; Burton IW; Cho S; Franzblau SG; Chen SN; Pauli GF J Nat Prod; 2017 Oct; 80(10):2630-2643. PubMed ID: 29035048 [TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial Rufomycin Analogues from Zhou B; Shetye G; Yu Y; Santarsiero BD; Klein LL; Abad-Zapatero C; Wolf NM; Cheng J; Jin Y; Lee H; Suh JW; Lee H; Bisson J; McAlpine JB; Chen SN; Cho SH; Franzblau SG; Pauli GF J Nat Prod; 2020 Mar; 83(3):657-667. PubMed ID: 32031795 [TBL] [Abstract][Full Text] [Related]
20. Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. a potent and selective series for further drug development. Lilienkampf A; Pieroni M; Wan B; Wang Y; Franzblau SG; Kozikowski AP J Med Chem; 2010 Jan; 53(2):678-88. PubMed ID: 20000577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]